Just published: Retinal Physician-Current Clinical Trials in Diabetic Macular Ed…
[ad_1]
Just published: Retinal Physician-Current Clinical Trials in Diabetic Macular Edema
Innovative therapies with durability & novel mechanisms include pan-VEGF Inhibitors, Ang2 inhibitors, plasma kallikrein inhibitors & anti-integrin therapies.
#eye #retina
https://t.co/lAvvtLQKfS
[ad_2]
Source by Thomas Ciulla, MD, MBA